BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33749340)

  • 21. The Prognostic Value of a Derived Neutrophil-Lymphocyte Ratio in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Fan W; Zhang Y; Gao X; Liu Y; Shi F; Liu J; Sun L
    Clin Appl Thromb Hemost; 2021; 27():10760296211034579. PubMed ID: 34286626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Wang H; Ning X; Zhu C; Yin D; Feng L; Xu B; Guan C; Dou K
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):787-792. PubMed ID: 30618111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Sun JM; Hong JC; Chen LL
    Dis Markers; 2019; 2019():4925767. PubMed ID: 31772687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor of Clinical Outcomes in CAD Patients After PCI.
    Fan L; Zhang ZL; Tang JN; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Clin Appl Thromb Hemost; 2022; 28():10760296221113345. PubMed ID: 35903893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort.
    Hou XG; Wu TT; Zheng YY; Yang HT; Yang Y; Ma YT; Xie X
    J Cardiovasc Transl Res; 2023 Oct; 16(5):1177-1183. PubMed ID: 37349658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Wu TT; Zheng YY; Xiu WJ; Wang WR; Xun YL; Ma YY; Kadir P; Pan Y; Ma YT; Xie X
    Front Cardiovasc Med; 2021; 8():616896. PubMed ID: 34307487
    [No Abstract]   [Full Text] [Related]  

  • 29. Atherogenic Index of Plasma, Triglyceride-Glucose Index and Monocyte-to-Lymphocyte Ratio for Predicting Subclinical Coronary Artery Disease.
    Si Y; Fan W; Han C; Liu J; Sun L
    Am J Med Sci; 2021 Sep; 362(3):285-290. PubMed ID: 33989563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study.
    Cheng MD; Tang JN; Liu ZY; Guo QQ; Zhang JC; Zhang ZL; Song FH; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Diab Vasc Dis Res; 2023; 20(4):14791641231193306. PubMed ID: 37561132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort.
    Gijsberts CM; Ellenbroek GHJM; Ten Berg MJ; Huisman A; van Solinge WW; Lam CS; Asselbergs FW; den Ruijter HM; Pasterkamp G; Hoefer IE; de Kleijn DP
    Am J Cardiol; 2017 Sep; 120(6):911-916. PubMed ID: 28779870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study.
    Xiang F; Chen R; Cao X; Shen B; Liu Z; Tan X; Ding X; Zou J
    Hemodial Int; 2018 Jan; 22(1):82-92. PubMed ID: 28403540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between fibrinogen levels and severity of coronary artery disease and long-term prognosis following percutaneous coronary intervention in patients with type 2 diabetes mellitus.
    Su H; Cao Y; Chen Q; Ye T; Cui C; Chen X; Yang S; Qi L; Long Y; Xiong S; Cai L
    Front Endocrinol (Lausanne); 2023; 14():1287855. PubMed ID: 38093962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis.
    Vakhshoori M; Nemati S; Sabouhi S; Shakarami M; Yavari B; Emami SA; Bondariyan N; Shafie D
    J Int Med Res; 2023 Oct; 51(10):3000605231204469. PubMed ID: 37848392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
    Cho KI; Ann SH; Singh GB; Her AY; Shin ES
    PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Derived Neutrophil-To-Lymphocyte Ratio With Prognosis of Coronary Heart Disease After PCI.
    Liu GQ; Zhang WJ; Shangguan JH; Zhu XD; Wang W; Guo QQ; Zhang JC; Wang K; Liu ZY; Song FH; Fan L; Zheng YY; Zhang JY
    Front Cardiovasc Med; 2021; 8():705862. PubMed ID: 34604350
    [No Abstract]   [Full Text] [Related]  

  • 38. Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Zheng YY; Wu TT; Chen Y; Hou XG; Yang Y; Ma X; Ma YT; Zhang JY; Xie X
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():572-578. PubMed ID: 31912975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention.
    Reed GW; Masri A; Griffin BP; Kapadia SR; Ellis SG; Desai MY
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease.
    Zheng YY; Wu TT; Guo QQ; Chen Y; Ma X; Ma YT; Zhang JY; Xie X
    Atherosclerosis; 2021 Jul; 328():1-10. PubMed ID: 34052667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.